Experts tout the benefits of micro-dosing cannabinoids

ROCKFORD, Ill. (WIFR) – As cannabinoids become more popular in Illinois, leaders in the industry find new ways people can benefit from it. “People are really looking for that level where the pain goes away, where they actually do have the pain relief and they can function and go through…

Continue Reading Experts tout the benefits of micro-dosing cannabinoids

How Cannabinoid Receptor Density Determines Personality

In From Bud to Brain, I traced how marijuana research gradually morphed from focusing on the cannabis plant (botany) to exploring the brain’s natural endocannabinoid system (neuroscience) and, incidentally, how it interacts with the cannabis plant’s chemistry. Without an understanding of this endocannabinoid system, it is impossible to explain how…

Continue Reading How Cannabinoid Receptor Density Determines Personality

Incannex Healthcare engages Catalent to develop psilocybin drug for clinical trials and potential commercialisation

Catalent will formulate and manufacture Incannex’s psilocybin drug for use in clinical trials and potential commercialisation. Incannex Healthcare (ASX: IHL) has reached another milestone in progressing its psilocybin drug product by engaging Catalent to formulate and manufacture the drug for use in clinical trials and potential wider commercialisation. Under the…

Continue Reading Incannex Healthcare engages Catalent to develop psilocybin drug for clinical trials and potential commercialisation

Cannabidiol Add-On in Glycosylphosphatidylinositol-Related Drug-Resistant Epilepsy

doi: 10.1089/can.2022.0255. Online ahead of print. Antonella Riva  1   2 , Gianluca D’Onofrio  1   2 , Angelica Pisati  2 , Roberta Roberti  3 , Elisabetta Amadori  1   2 , Friedrich Bosch  4 , Carolina Fischinger Moura de Souza  5 , Ashley Thomas  6 , Emilio Russo  3 , Pasquale Striano  1   2 , Allan Bayat  7…

Continue Reading Cannabidiol Add-On in Glycosylphosphatidylinositol-Related Drug-Resistant Epilepsy

Synthetic cannabinoid maker Nalu Bio raises $12 million

Nalu Bio, a producer of synthetic cannabinoids, said it raised $12 million in a Series A funding round led by Intrinsic Capital Partners, a Pennsylvania-based investment firm focused on life science and technology businesses in the legal marijuana and hemp industries. The investment in the San Francisco-based company, announced in…

Continue Reading Synthetic cannabinoid maker Nalu Bio raises $12 million

LOINC 72803-0 JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine

Part Descriptions LP157292-6   JWH-250 5-carboxypentylSynthetic cannabinoids interact with the same brain receptors as THC (the active drug present in marijuana) and have been demonstrated to produce similar effects. The drug is typically sprayed on botanical material and smoked, although it can be ingested in liquid or powder form. Products…

Continue Reading LOINC 72803-0 JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine

Exploring the Benefits of Cannabinoid PHC for Pain Management

Chronic pain affects millions worldwide and can greatly diminish one’s quality of life. While various medications are available for pain management, many have side effects and can be addictive. This has led researchers to explore alternative treatments, including cannabinoids. Among the many cannabinoids in the cannabis plant, PHC has shown…

Continue Reading Exploring the Benefits of Cannabinoid PHC for Pain Management

Identification of circular RNAs of Cannabis sativa L. potentially involved in the biosynthesis of cannabinoids

We identified circRNAs in the Cannabis sativa L. genome and examined their association with 28 cannabinoids in three tissues of C. sativa. Nine circRNAs are potentially involved in the biosynthesis of six cannabinoids. Cannabis sativa L. has been widely used in the production of medicine, textiles, and food for over…

Continue Reading Identification of circular RNAs of Cannabis sativa L. potentially involved in the biosynthesis of cannabinoids

The Role of Cigarillo Flavor in the Co-Use of Cigarillos and Cannabis among Young Adults

Background: Research suggests flavor facilitates cigarillo use, but it is unknown if flavor impacts patterns of co-use of cigarillos and cannabis (“co-use”), which is common among young adult smokers. This study’s aim was to determine the role of the cigarillo flavor in co-use among young adults. Methods: Data were collected…

Continue Reading The Role of Cigarillo Flavor in the Co-Use of Cigarillos and Cannabis among Young Adults

The Role of Cigarillo Flavor in the Co-Use of Cigarillos and Cannabis among Young Adults

Background: Research suggests flavor facilitates cigarillo use, but it is unknown if flavor impacts patterns of co-use of cigarillos and cannabis (“co-use”), which is common among young adult smokers. This study’s aim was to determine the role of the cigarillo flavor in co-use among young adults. Methods: Data were collected…

Continue Reading The Role of Cigarillo Flavor in the Co-Use of Cigarillos and Cannabis among Young Adults